Concepedia

Mika Lahdenkari

ML

Statistics

Publications

24

Citations

705

H-Index

17

Active since

2001

Affiliations

Institute for Molecular Medicine Finland(Current)

Finnish Institute for Health and Welfare

Public Health Institute

Helsinki University Hospital

University of Alabama at Birmingham

Mika Lahdenkari is an author at Institute for Molecular Medicine Finland specializing in infectious diseases, pneumococcal disease, and medicine.

Publications per year

2001–2020

24

Publications

24

Effects of Ageing and Gender on Naturally Acquired Antibodies to Pneumococcal Capsular Polysaccharides and Virulence-Associated Proteins

Birgit Simell, Mika Lahdenkari, Antti Reunanen et al. · Clinical and Vaccine Immunology · 2008 · 111 citations · Full text

, , +16

Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life

Outi Vaarala, Jukka Jokinen, Mika Lahdenkari et al. · The Pediatric Infectious Disease Journal · 2017 · 58 citations

, , +17

Development of antibodies against pneumococcal proteins α-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media

Peter V. Adrian, Debby Bogaert, Maartje Oprins et al. · Vaccine · 2004 · 48 citations

, , +11

Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media

Satu Rapola, Terhi Kilpi, Mika Lahdenkari et al. · The Pediatric Infectious Disease Journal · 2001 · 43 citations

, , +9

Long-term Effect of Pneumococcal Conjugate Vaccines on Tympanostomy Tube Placements

Ilona Sarasoja, Jukka Jokinen, Mika Lahdenkari et al. · The Pediatric Infectious Disease Journal · 2012 · 41 citations

, , +17

1–5 of 24